scholarly article | Q13442814 |
P356 | DOI | 10.1093/OXFORDJOURNALS.AJE.A115439 |
P698 | PubMed publication ID | 2589305 |
P2093 | author name string | Chen CJ | |
Wu MM | |||
Hwang YH | |||
Kuo TL | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | arsenic | Q871 |
P304 | page(s) | 1123-1132 | |
P577 | publication date | 1989-12-01 | |
P1433 | published in | American Journal of Epidemiology | Q4744243 |
P1476 | title | Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases | |
P478 | volume | 130 |
Q26774379 | A Systematic Review and Meta-Regression Analysis of Lung Cancer Risk and Inorganic Arsenic in Drinking Water |
Q24814268 | A case of Bowen's disease and small-cell lung carcinoma: long-term consequences of chronic arsenic exposure in Chinese traditional medicine |
Q57935803 | A comparative study on arsenic and humic substances in alluvial aquifers of Bengal delta plain (NW Bangladesh), Chianan plain (SW Taiwan) and Lanyang plain (NE Taiwan): implication of arsenic mobilization mechanisms |
Q44447019 | A comparison of several methods to test for the existence of a monotonic dose-response relationship in clinical and epidemiological studies |
Q46941914 | A dose-response meta-analysis of chronic arsenic exposure and incident cardiovascular disease |
Q36755541 | A novel role of the NRF2 transcription factor in the regulation of arsenite-mediated keratin 16 gene expression in human keratinocytes. |
Q34262534 | A preliminary assessment of low level arsenic exposure and diabetes mellitus in Cyprus |
Q28396900 | A prospective cohort study of stroke mortality and arsenic in drinking water in Bangladeshi adults |
Q35198557 | A prospective study of arsenic exposure from drinking water and incidence of skin lesions in Bangladesh |
Q28385161 | A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh |
Q34052589 | Age adjustment in ecological studies: using a study on arsenic ingestion and bladder cancer as an example. |
Q38732732 | Arsenic Exposure and Immunotoxicity: a Review Including the Possible Influence of Age and Sex. |
Q33830244 | Arsenic and cardiovascular disease: new evidence from the United States |
Q26823611 | Arsenic and human health: epidemiologic progress and public health implications |
Q35089506 | Arsenic and lung disease mortality in Bangladeshi adults |
Q89377225 | Arsenic and other trace elements in groundwater and human urine in Ha Nam province, the Northern Vietnam: contamination characteristics and risk assessment |
Q24553598 | Arsenic cancer risk confounder in southwest Taiwan data set |
Q35029998 | Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland |
Q45306810 | Arsenic contamination in water, soil, sediment and rice of central India |
Q39850446 | Arsenic content in ground and canal waters of Punjab, North-West India |
Q23919503 | Arsenic exposure accelerates atherogenesis in apolipoprotein E-/-mice |
Q26851757 | Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses |
Q28391899 | Arsenic exposure and cancer mortality in a US-based prospective cohort: the strong heart study |
Q36306130 | Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence |
Q36354209 | Arsenic exposure and cardiovascular disease: an updated systematic review |
Q22306134 | Arsenic exposure and hypertension: a systematic review |
Q28394700 | Arsenic exposure and the induction of human cancers |
Q37640070 | Arsenic exposure from drinking water and dyspnoea risk in Araihazar, Bangladesh: a population-based study |
Q28388293 | Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study |
Q37633197 | Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study |
Q89843696 | Arsenic exposure is associated with significant upper tract urothelial carcinoma health care needs and elevated mortality rates |
Q30494905 | Arsenic exposure perturbs epithelial-mesenchymal cell transition and gene expression in a collagen gel assay |
Q37039435 | Arsenic in Drinking Water and Lung Cancer Mortality in the United States: An Analysis Based on US Counties and 30 Years of Observation (1950-1979). |
Q47410300 | Arsenic in drinking water and adverse pregnancy outcome in an arseniasis-endemic area in northeastern Taiwan |
Q26343779 | Arsenic in drinking water and prostate cancer in Illinois counties: an ecologic study |
Q33870323 | Arsenic in drinking water and urinary tract cancers: a systematic review of 30 years of epidemiological evidence |
Q36448664 | Arsenic in drinking-water and risk for cancer in Denmark |
Q28396230 | Arsenic is cytotoxic and genotoxic to primary human lung cells |
Q46494442 | Arsenic levels in ground water and cancer incidence in Idaho: an ecologic study |
Q53129536 | Arsenic levels in the groundwater of Korea and the urinary excretion among contaminated area. |
Q34636333 | Arsenic methylation patterns before and after changing from high to lower concentrations of arsenic in drinking water |
Q36543135 | Arsenic reduction in drinking water and improvement in skin lesions: a follow-up study in Bangladesh |
Q35031342 | Arsenic risk assessment |
Q73916792 | Arsenic species contents at aquaculture farm and in farmed mouthbreeder (Oreochromis mossambicus) in blackfoot disease hyperendemic areas |
Q30339021 | Arsenic toxicity, mutagenesis, and carcinogenesis--a health risk assessment and management approach. |
Q33572954 | Arsenic treatment increase Aurora-A overexpression through E2F1 activation in bladder cells |
Q28389076 | Arsenic, internal cancers, and issues in inference from studies of low-level exposures in human populations |
Q64099547 | Arsenite malignantly transforms human prostate epithelial cells in vitro by gene amplification of mutated KRAS |
Q31834318 | Arsenite stimulates plasma membrane NADPH oxidase in vascular endothelial cells |
Q25257360 | Assessing the measurement precision of various arsenic forms and arsenic exposure in the National Human Exposure Assessment Survey (NHEXAS). |
Q41998527 | Assessment of natural arsenic in groundwater in Cordoba Province, Argentina. |
Q27022285 | Association between Arsenic Exposure and Diabetes: A Meta-Analysis |
Q34486646 | Association between the clastogenic effect in peripheral lymphocytes and human exposure to arsenic through drinking water |
Q24530205 | Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern Taiwan |
Q36755586 | Associations between arsenic in drinking water and pterygium in southwestern Taiwan. |
Q37635891 | Baseline comorbidities in a skin cancer prevention trial in Bangladesh |
Q57194241 | Benchmark dose estimation based on epidemiologic cohort data |
Q35561093 | Biological monitoring of occupational exposure to inorganic arsenic |
Q36933640 | Bladder cancer mortality and private well use in New England: an ecological study |
Q51546088 | Bladder/lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150 μg/L) well water arsenic levels--an exploration of the dose-response Poisson analysis. |
Q36112021 | Blood Pressure Changes in Relation to Arsenic Exposure in a U.S. Pregnancy Cohort. |
Q64903301 | C. elegans-An Emerging Model to Study Metal-Induced RAGE-Related Pathologies. |
Q46584280 | Cancer Risks Associated with Arsenic: Lamm et al. Respond |
Q34804124 | Cancer excess after arsenic exposure from contaminated milk powder |
Q47999604 | Cancer incidence and soil arsenic exposure in a historical gold mining area in Victoria, Australia: a geospatial analysis |
Q35994544 | Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water |
Q42613956 | Cancer risks associated with arsenic in drinking water |
Q24554413 | Cancer risks from arsenic in drinking water |
Q53457975 | Carcinogenic risks of inorganic arsenic in perspective. |
Q24815524 | Carcinogenicity of trichloroethylene |
Q33562969 | Changes in urinary arsenic methylation profiles in a 15-year interval after cessation of arsenic ingestion in southwest Taiwan |
Q23923184 | Chronic arsenic exposure and risk of infant mortality in two areas of Chile |
Q37384803 | Chronic exposure of arsenic via drinking water and its adverse health impacts on humans |
Q47591335 | Clean and facile solution synthesis of iron(III)-entrapped gamma-alumina nanosorbents for arsenic removal |
Q28534141 | Comparison of Barium and Arsenic Concentrations in Well Drinking Water and in Human Body Samples and a Novel Remediation System for These Elements in Well Drinking Water |
Q51165330 | Comparison of health effects between individuals with and without skin lesions in the population exposed to arsenic through drinking water in West Bengal, India. |
Q33899180 | Confounding variables in the environmental toxicology of arsenic |
Q35037752 | Coronary atherosclerosis and somatic mutations: an overview of the contributive factors for oxidative DNA damage. |
Q26785988 | Current understanding of mdig/MINA in human cancers |
Q43895086 | Decrease of fibrinolytic activity in human endothelial cells by arsenite |
Q51515847 | Decreasing trend in renal disease mortality after cessation from arsenic exposure in a previous arseniasis-endemic area in southwestern Taiwan. |
Q51018447 | Delimitation of arsenic-contaminated groundwater using risk-based indicator approaches around blackfoot disease hyperendemic areas of southern Taiwan. |
Q24815516 | Detection of excess arsenic-related cancer risks |
Q37525139 | Dietary B vitamin intakes and urinary total arsenic concentration in the Health Effects of Arsenic Longitudinal Study (HEALS) cohort, Bangladesh |
Q35889155 | Does arsenic exposure increase the risk for liver cancer? |
Q43365380 | Does arsenic exposure increase the risk for prostate cancer? |
Q51146925 | Does arsenic exposure increase the risk of development of peripheral vascular diseases in humans? |
Q104557020 | Does environment quality and public spending on environment promote life expectancy in China? Evidence from a nonlinear autoregressive distributed lag approach |
Q37253194 | Dose- and time-dependent response of human leukemia (HL-60) cells to arsenic trioxide treatment |
Q26800750 | Drinking Water Arsenic Contamination, Skin Lesions, and Malignancies: A Systematic Review of the Global Evidence |
Q34834122 | Drinking water and cancer |
Q35029875 | Drinking water arsenic in Utah: A cohort mortality study |
Q41124995 | Effect of heme oxygenase-1 gene promoter polymorphism on cancer risk by histological subtype: A prospective study in arseniasis-endemic areas in Taiwan. |
Q73502698 | Effect of hepatic methyl donor status on urinary excretion and DNA damage in B6C3F1 mice treated with sodium arsenite |
Q28386467 | Environmental arsenic exposure and serum matrix metalloproteinase-9 |
Q34993494 | Environmental health surveillance: indicators for freshwater ecosystems. |
Q34371580 | Evaluation of the carcinogenicity of inorganic arsenic |
Q34547699 | Evidence from Chile that arsenic in drinking water may increase mortality from pulmonary tuberculosis |
Q37188943 | Examination of the effects of arsenic on glucose homeostasis in cell culture and animal studies: development of a mouse model for arsenic-induced diabetes |
Q57293749 | Exposure to trace elements and risk of skin cancer: A systematic review of epidemiologic studies |
Q35148220 | Field Deployable Method for Arsenic Speciation in Water |
Q35610088 | Fluid intake and risk of bladder and other cancers |
Q35426674 | Genetic polymorphisms in glutathione S-transferase (GST) superfamily and risk of arsenic-induced urothelial carcinoma in residents of southwestern Taiwan. |
Q46632119 | Genetic polymorphisms of oxidative and antioxidant enzymes and arsenic-related hypertension |
Q92859869 | Genome-wide CRISPR screen identifies suppressors of endoplasmic reticulum stress-induced apoptosis |
Q35633033 | Global gene expression changes in human urothelial cells exposed to low-level monomethylarsonous acid |
Q44887921 | Health importance of arsenic in drinking water and food. |
Q41939705 | Health risk assessment of groundwater arsenic pollution in southern Taiwan |
Q90277334 | Higher risk of hyperglycemia with greater susceptibility in females in chronic arsenic-exposed individuals in Bangladesh |
Q41922882 | Histopathology of Cervical Cancer and Arsenic Concentration in Well Water: An Ecological Analysis |
Q53489597 | Human carcinogenesis by arsenic. |
Q57946325 | Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers |
Q57929665 | Impact of prenatal arsenic exposure on chronic adult diseases |
Q28389104 | In utero and early life arsenic exposure in relation to long-term health and disease |
Q28388283 | In utero and postnatal exposure to arsenic alters pulmonary structure and function |
Q28396600 | In utero arsenic exposure induces early onset of atherosclerosis in ApoE-/- mice |
Q37141838 | In-vitro cytotoxic and genotoxic effects of arsenic trioxide on human leukemia (HL-60) cells using the MTT and alkaline single cell gel electrophoresis (Comet) assays |
Q42583516 | In-vitro relationship between protein-binding and free drug concentrations of a water-soluble selective beta-adrenoreceptor antagonist (atenolol) and its interaction with arsenic |
Q37167306 | Increased mortality associated with well-water arsenic exposure in Inner Mongolia, China. |
Q28390288 | Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood |
Q35079230 | Individual variations in inorganic arsenic metabolism associated with AS3MT genetic polymorphisms. |
Q35607441 | Induction of human squamous cell-type carcinomas by arsenic |
Q35941774 | Inorganic arsenic and basal cell carcinoma in areas of Hungary, Romania, and Slovakia: a case-control study |
Q28383469 | Inorganic arsenic and human prostate cancer |
Q40682771 | Inorganic arsenite-induced malignant transformation of human prostate epithelial cells |
Q35574651 | Interaction between arsenic exposure from drinking water and genetic polymorphisms on cardiovascular disease in Bangladesh: a prospective case-cohort study |
Q35571581 | Invited Reviews: Carcinogenic and Systemic Health Effects Associated with Arsenic Exposure—A Critical Review |
Q43314714 | Ischemic heart disease mortality reduction in an arseniasis-endemic area in southwestern Taiwan after a switch in the tap-water supply system |
Q28390690 | Liver is a target of arsenic carcinogenesis |
Q37511215 | Long-Term Prospective Study of 6104 Survivors of Arsenic Poisoning During Infancy Due to Contaminated Milk Powder in 1955 |
Q34167512 | Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan. |
Q38608212 | Low-level arsenic exposure from drinking water is associated with prostate cancer in Iowa. |
Q37265639 | Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis |
Q57941569 | Lung Cancer Risk and Low (≤50 μg/L) Drinking Water Arsenic Levels for US Counties (2009⁻2013)-A Negative Association |
Q28392929 | Lung cancer in a U.S. population with low to moderate arsenic exposure |
Q46180106 | Lung, Bladder, and Kidney Cancer Mortality 40 Years After Arsenic Exposure Reduction |
Q35672221 | Mechanisms of acquired androgen independence during arsenic-induced malignant transformation of human prostate epithelial cells |
Q33859421 | Mechanisms of nephrotoxicity from metal combinations: a review |
Q34567906 | Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment |
Q24545241 | Methylation study of a population environmentally exposed to arsenic in drinking water |
Q29249056 | Mitigating dietary arsenic exposure: Current status in the United States and recommendations for an improved path forward |
Q23913039 | Mortality patterns among workers exposed to arsenic, cadmium, and other substances in a copper smelter |
Q36079946 | Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver disease and malnutritional status |
Q25256887 | Municipal distribution of bladder cancer mortality in Spain: possible role of mining and industry |
Q36620304 | Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan |
Q24815532 | N-Acetyltransferase 2 polymorphism in patients with Spanish toxic oil syndrome |
Q37398906 | Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects |
Q24812702 | Pathology related to chronic arsenic exposure |
Q28395923 | Pharmacokinetic and Genomic Effects of Arsenite in Drinking Water on Mouse Lung in a 30-Day Exposure |
Q47672770 | Photochemical oxidation of As(III) by vacuum-UV lamp irradiation |
Q74440986 | Potential lifestyle and dietary supplement options for the prevention and postdiagnosis of bladder cancer |
Q80930485 | Prevalence of chronic diseases in adults exposed to arsenic-contaminated drinking water |
Q24813433 | Prevalence of non-insulin-dependent diabetes mellitus and related vascular diseases in southwestern arseniasis-endemic and nonendemic areas in Taiwan |
Q51045755 | Primary intracerebral hemorrhage mortality reduction after installation of a tap-water supply system in an arseniasis-endemic area in southwestern Taiwan. |
Q51446929 | Probabilistic framework for assessing the arsenic exposure risk from cooked fish consumption. |
Q89597887 | Prostate Cancer Incidence in U.S. Counties and Low Levels of Arsenic in Drinking Water |
Q35752436 | Pulmonary biomarkers based on alterations in protein expression after exposure to arsenic |
Q37738941 | Reassessing the Link between Airborne Arsenic Exposure among Anaconda Copper Smelter Workers and Multiple Causes of Death Using the Parametric g-Formula |
Q40631694 | Relationship between arsenic-containing drinking water and skin cancers in the arseniasis endemic areas in Taiwan |
Q39891853 | Removal of arsenic from water: effects of competing anions on As(III) removal in KMnO4-Fe(II) process |
Q26322663 | Reproductive and developmental effects associated with chronic arsenic exposure |
Q57383336 | Requirements for a Biologically Realistic Cancer Risk Assessment for Inorganic Arsenic |
Q35952226 | Risk of death from cardiovascular disease associated with low-level arsenic exposure among long-term smokers in a US population-based study |
Q35135577 | Risk of internal cancers from arsenic in drinking water |
Q59844521 | Sampling private wells at past homes to estimate arsenic exposure: A methodologic study in New England |
Q88160507 | Shallow groundwater quality and associated non-cancer health risk in agricultural areas (Poyang Lake basin, China) |
Q46810541 | Sodium arsenate induce changes in fatty acids profiles and oxidative damage in kidney of rats |
Q57466669 | Sodium arsenite exposure inhibits histone acetyltransferase p300 for attenuating H3K27ac at enhancers in mouse embryonic fibroblast cells |
Q90240126 | State of the science review of the health effects of inorganic arsenic: Perspectives for future research |
Q34137121 | Systemic uptake of inhaled arsenic in rabbits |
Q84439013 | The association between arsenic exposure from drinking water and cerebrovascular disease mortality in Taiwan |
Q34330882 | The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem |
Q24815343 | The effect of arsenic mitigation interventions on disease burden in Bangladesh |
Q33848088 | The global burden of disease for skin, lung, and bladder cancer caused by arsenic in food |
Q53376745 | The lack of a specific association between arsenic in drinking water and hepatocellular carcinoma. |
Q37328286 | The role of oxidative stress in carcinogenesis induced by metals and xenobiotics |
Q57576088 | Trace Element Groundwater Pollution Hazard in Regional Hydrogeological Systems (Empordà Basin, NE Spain) |
Q44313185 | Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice |
Q35597128 | Unfolded protein response signaling and MAP kinase pathways underlie pathogenesis of arsenic-induced cutaneous inflammation |
Q43369558 | Uptake of arsenite by synthetic layered double hydroxides |
Q37295842 | Urinary porphyrins in patients with endemic chronic arsenic poisoning caused by burning coal in China |
Q34691948 | Utility of recent studies to assess the National Research Council 2001 estimates of cancer risk from ingested arsenic |
Q41924474 | VULNERABILITY OF LOW-ARSENIC AQUIFERS TO MUNICIPAL PUMPING IN BANGLADESH. |
Q50792782 | Zonal management of multi-purposes groundwater utilization based on water quality and impact on the aquifer. |
Q68650923 | [Features and functions of environmental epidemiology] |
Search more.